Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease gastric cancer
Phenotype C0011860|type 2 diabetes
Sentences 9
PubMedID- 25844356 The effect of long ry gastrojejunostomy after gastrectomy for diabetes control could be contentious but an applicable reconstruction method for diabetes control in gastric cancer patients with type 2 diabetes and bmi < 35 kg/m2.
PubMedID- 23973197 Short-term glucose metabolism and gut hormone modulations after billroth ii gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.
PubMedID- 25815791 The aim of the present study was, therefore, to investigate mdr alterations in gastric cancer combined with type 2 diabetes.
PubMedID- 24132827 Outcome after curative surgery for gastric cancer patients with type 2 diabetes.
PubMedID- 26194372 Conclusion: long-term low-dose aspirin use was associated with reduced gastric cancer risk in patients with hypertension or type 2 diabetes.
PubMedID- 22228970 Outcome after gastrectomy in gastric cancer patients with type 2 diabetes.
PubMedID- 24224094 Two meta-analyses explored the incidence of gastric cancer in people with type 2 diabetes in case-control and cohort studies [8, 9].
PubMedID- 25190521 Background: this study was conducted to evaluate course of diabetes after gastrectomy according to type of reconstruction performed for gastric cancer in patients with type 2 diabetes.
PubMedID- 22066116 In the patients of gastric cancer with type 2 diabetes and high body mass index, roux-en-y gastrojejunostomy method is expected to be better than billroth i methods to resolve type 2 diabetes and obesity [21].

Page: 1